Search Results - "Budzinskaya, Maria"

Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies by Plyukhova, Anna A, Budzinskaya, Maria V, Starostin, Kirill M, Rejdak, Robert, Bucolo, Claudio, Reibaldi, Michele, Toro, Mario D

“…Since the efficacy of ranibizumab (RBZ), bevacizumab (BVZ) and aflibercept (AFB) is comparable in neovascular age-related macular degeneration (AMD), we…”
Get full text

Diabetic Retinopathy Diagnosis based on Convolutional Neural Network in the Russian Population: A Multicenter Prospective Study by Gognieva, Daria, Durzhinskaya, Madina, Vorobyeva, Irina, Chomakhidze, Petr, Suvorov, Alexander, Kuznetsova, Natalia, Bektimirova, Alina, Al-Dwa, Baraah, Abdullaev, Magomed, Yusef, Yusef, Pavlov, Vladislav, Budzinskaya, Maria, Sychev, Dmitry, Moshetova, Larisa, Kopylov, Philipp

“…Diabetic retinopathy is the most common complication of diabetes mellitus and is one of the leading causes of vision impairment globally, which is also…”
Get more information

Ocular flora in patients undergoing intravitreal injections: antibiotic resistance patterns and susceptibility to antiseptic picloxydine by Budzinskaya, Maria V, Khalatyan, Anait S, Strakhovskaya, Marina G, Zhukhovitsky, Vladimir G

“…To study antibiotic resistance patterns and susceptibility to eye antiseptic picloxydine of conjunctival flora in patients undergoing intravitreal injections…”
Get full text

Biomarkers for diabetic retinopathy by Budzinskaya, Maria V., Lipatov, Dmitry V., Pavlov, Vladislav G., Petrachkov, Denis V.

“…A data analysis on the actual direction of biomedicine, the study of biomarkers in diabetic retinopathy (DR), was done. Biomarkers identification is important…”
Get full text

TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 by Khanani, Arshad M, Kotecha, Aachal, Chang, Andrew, Chen, Shih-Jen, Chen, Youxin, Guymer, Robyn, Heier, Jeffrey S, Holz, Frank G, Iida, Tomohiro, Ives, Jane A, Lim, Jennifer I, Lin, Hugh, Michels, Stephan, Quezada Ruiz, Carlos, Schmidt-Erfurth, Ursula, Silverman, David, Singh, Rishi, Swaminathan, Balakumar, Willis, Jeffrey R, Tadayoni, Ramin

“…To evaluate 2-year efficacy, durability, and safety of the bispecific antibody faricimab, which inhibits both angiopoietin-2 and VEGF-A.PURPOSETo evaluate…”
Get full text

Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials by Wong, Tien Y, Haskova, Zdenka, Asik, Kemal, Baumal, Caroline R, Csaky, Karl G, Eter, Nicole, Ives, Jane A, Jaffe, Glenn J, Korobelnik, Jean-François, Lin, Hugh, Murata, Toshinori, Ruamviboonsuk, Paisan, Schlottmann, Patricio G, Seres, András I, Silverman, David, Sun, Xiaodong, Tang, Yannan, Wells, John A, Yoon, Young Hee, Wykoff, Charles C

“…To evaluate the 2-year efficacy, durability, and safety of dual angiopoietin-2 and vascular endothelial growth factor (VEGF) A pathway inhibition with…”
Get full text

Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial by Bressler, Susan B, Barve, Abhijit, Ganapathi, Prasanna C, Beckmann, Katrin, Apte, Rajendra S, Marcus, Dennis M, Baumane, Kristine, Agarwal, Somesh, Oleksy, Piotr, Reichstein, David A, Patel, Sunil S, Ernest, Jan, Dégi, Rozsa, Gupta, Vishali, Kishino, Genichiro, Kamei, Motohiro, Loganathan, Subramanian

“…Biosimilars may be lower-cost alternatives to originator biologic products, potentially offering expanded access or reduced economic burden, but have not been…”
Get more information

Sensitivity of antibiotic resistant coagulase-negative staphylococci to antiseptic piсloxydin in eye drops Vitabact by Khalatyan, Anait, Budzinskaya, Maria, Kholina, Ekaterina, Strakhovskaya, Marina, Kolyshkina, Nadezhda, Kovalenko, Ilya, Zhukhovitsky, Vladimir

“…Background. Coagulase-negative staphylococci (CNS), primarily Staphylococcus epidermidis, predominate in the normal microflora of the eye. However, due to…”
Get full text

Automated analysis of retinal microcirculation in type 1 diabetes mellitus by Yusef, Yu. N., Durzhinskaya, M. H., Pavlov, V. G., Petrachkov, D. V., Gurevich, I. B., Yashina, V. V., Tleubaev, A. T., Fadeyev, V. V., Poluboyarinova, I. V., Goldsmid, A. E., Karamullina, R. А., Lipatov, D. V., Budzinskaya, M. V.

“…BACKGROUND: The paper is dedicated to the assessment of the retinal microvasculature in patients with type 1 diabetes mellitus (DM) with various features of…”
Get full text

An information leaflet for patients receiving treatment by intravitreal drug injections. Recommendations of the Expert Council on retinal and optic nerve diseases of the Association of Ophthalmologists, an All-Russian public organization by Neroev, V. V., Korotkikh, S. A., Bobykin, E. V., Zaytseva, O. V., Lisochkina, A. B., Brovkina, A. F., Budzinskaya, M. V., Gatsu, M. V., Grigoryeva, N. N., Izmaylov, A. S., Karlova, E. V., Kovalevskaya, M. A., Nechiporenko, P. A., Panova, I. E., Ryabtseva, A. A., Simonova, S. V., Tultseva, S. N., Fursova, A. Zh, Shadrichev, F. E., Shishkin, M. M.

“…The widespread introduction of intravitreal drug injections into clinical practice has highlighted a number of issues to be solved, including the risk of…”
Get full text